← Back to Search

Other

Omega-3 Fatty Acids for Muscle Health

N/A
Recruiting
Research Sponsored by Dr. Chris McGlory, PhD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0, 6, 8, 16, 20, and 22 weeks.
Awards & highlights

Study Summary

This trial looks at how omega-3 fatty acid intake affects skeletal muscle strength/growth and if it's different for men and women. It also looks at how quickly omega-3 fatty acids are washed out of muscle when you stop taking them.

Who is the study for?
This trial is for recreationally active men and women aged 19-30, not pregnant, with a BMI of 18-29. Participants must be COVID-19 vaccinated per Queen's University guidelines (unless exempt), not allergic to fish, and free from musculoskeletal injuries or serious illnesses like cancer within the last five years.Check my eligibility
What is being tested?
The study investigates how omega-3 fatty acids from fish oil supplements affect muscle strength and growth over time. It will also look at whether biological sex influences these effects and how long it takes for omega-3s to leave the body after stopping supplementation.See study design
What are the potential side effects?
While specific side effects are not listed in this summary, common reactions to omega-3 supplements can include a fishy taste in the mouth, bad breath, heartburn, nausea, gastrointestinal discomfort, diarrhea, headache, odoriferous sweat.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0, 6, 8, 16, 20, and 22 weeks.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0, 6, 8, 16, 20, and 22 weeks. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in skeletal muscle EPA and DHA content
Secondary outcome measures
Changes in circulating CRP concentrations
Changes in circulating TNFa concentrations
Changes in circulating glucose concentrations
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Fish Oil GroupExperimental Treatment1 Intervention
All participants will be placed in this group
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Fish oil
2014
Completed Phase 4
~1830

Find a Location

Who is running the clinical trial?

Dr. Chris McGlory, PhDLead Sponsor
2 Previous Clinical Trials
50 Total Patients Enrolled
Queen's UniversityLead Sponsor
366 Previous Clinical Trials
121,709 Total Patients Enrolled

Media Library

Fish oil (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05971147 — N/A
Skeletal Muscle Metabolism Research Study Groups: Fish Oil Group
Skeletal Muscle Metabolism Clinical Trial 2023: Fish oil Highlights & Side Effects. Trial Name: NCT05971147 — N/A
Fish oil (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05971147 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this experiment include elderly participants?

"Per the terms of this particular trial, individuals must be aged between 19 and 30 to qualify for enrollment."

Answered by AI

Is it possible to partake in this research?

"This clinical trial is recruiting 28 individuals that have skeletal muscle metabolism and are within the age range of 19 to 30. Qualifying participants can apply for this experimental research."

Answered by AI

Are there remaining vacancies available to participants in this experiment?

"Clinicaltrials.gov confirms that this medical study, originally posted on August 1st 2023 and recently updated July 31st of the same year, is not actively recruiting patients at present. Though, there are alternative clinical trials currently enrolling individuals."

Answered by AI
~0 spots leftby May 2024